[Guideline 'Precautionary measures for contrast media containing iodine']

Area of Science:

• Radiology
• Nephrology
• Clinical Guideline Development

Context:

• Iodine-containing contrast media are widely used, with 0.5-1 million annual injections in the Netherlands.
• Despite advancements to low-osmolar, nonionic agents, contrast-induced nephropathy remains a clinical concern.
• A guideline was developed by the Radiological Society of the Netherlands and the Dutch Institute for Healthcare Improvement (CBO).

Purpose:

• To provide evidence-based recommendations for the intravascular use of iodine-containing contrast media.
• To define risk factors for contrast-induced nephropathy, particularly impaired renal function.
• To outline preventive strategies and management protocols for patients receiving contrast media.

Summary:

• The guideline identifies impaired renal function as a major risk factor, recommending glomerular filtration rate (GFR) measurement using the MDRD study formula.
• Key preventive measures include limiting contrast agent volume and ensuring adequate hydration with sodium chloride 0.9% infusion.
• Metformin should be discontinued if GFR < 60 ml/min/1.73 m2 and restarted after 2 days if renal function is stable. Prophylaxis is only recommended for prior severe adverse reactions.

Impact:

• Aims to reduce the incidence of contrast-induced nephropathy in patients undergoing procedures with intravascular contrast media.
• Provides clear, actionable guidance for clinicians to optimize patient safety and renal protection.
• Standardizes the management of patients at risk, improving clinical outcomes and healthcare quality.